The global insulin pump market, valued at USD 4.86 billion in 2022, is poised for substantial growth, projected to reach USD 15.5 billion by 2032 with a CAGR of 12.8% during 2023-2032. This growth is driven by several factors, including the rising prevalence of diabetes and the increasing preference for insulin pump.
Designed to be consumed like any other tablet, the oral insulin pill has undergone rigorous testing on various animal models, including mice, rats, and baboons.
For diabetics, the proper insulin can be crucial to everyday life and recently, there have been shortages of various medications.Certain types of insulins ha